Target intelligence / Profile preview

Multiple regenerative cell types

Molecular classification
Cell-based therapy, Other
01

Overview

Multiple regenerative cell types refers to a diverse group of cells, including stem cells (embryonic, induced pluripotent, and adult) and progenitor cells, that possess the capacity to self-renew and differentiate into specialized cell lineages (NIH, 2021). These cells are central to the field of regenerative medicine, where they are utilized to replace or repair damaged tissues and organs. Rather than being a single molecular target, they represent a therapeutic modality or a biological system that can be modulated by exogenous factors or administered directly as cell-based therapies (StatPearls, 2023). Their biological functions include tissue homeostasis, wound healing, and immunomodulation through the secretion of various cytokines and growth factors (Nature Reviews Molecular Cell Biology, 2018). In clinical settings, they are explored for treating conditions such as myocardial infarction, neurodegenerative diseases, and orthopedic injuries. However, challenges such as the risk of tumorigenesis, immune rejection, and the need for precise control over differentiation remain significant hurdles in their therapeutic application (FDA, 2023).

Other names
Stem cellsProgenitor cellsRegenerative cellsCell-based therapiesMultipotent cellsPluripotent cells
02

Mechanism of action

Regenerative cell types function through direct differentiation into functional tissue cells or by secreting paracrine factors (e.g., cytokines, growth factors, and extracellular vesicles) that promote endogenous repair, reduce inflammation, and stimulate angiogenesis (Nature Reviews Molecular Cell Biology, 2018).

03

Biological functions

Cell differentiationTissue regenerationCell proliferationImmunomodulationParacrine signaling
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseOrthopedic injuriesAutoimmune diseaseHematological disorders
05

Safety considerations

TumorigenicityImmunogenicityEctopic tissue formationGraft-versus-host diseaseEthical concerns
06

Interacting drugs

Filgrastim

4 more in the full profile.

07

Biomarkers

CD34CD133CD73CD90CD105OCT4NANOGSOX2

Beyond the preview

Go deeper on Multiple regenerative cell types.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple regenerative cell types.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call